Philippe Romagnoli serves as Executive at Omrix Biopharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Philippe Romagnoli has executed 6 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 4, 2008 involved receiving (via award) 2,000 shares valued at $0.
Philippe Romagnoli currently holds 119,627 shares of Omrix Biopharmaceuticals, Inc. (OMRI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Philippe Romagnoli has been a net seller of OMRI stock. They have purchased $375.8K and sold $2.0M worth of shares.
Philippe Romagnoli's most recent insider trade was on Sep 4, 2008, when they sold 2,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $13.59 |
| Discretionary |
| Mar 20, 2008 | OMRI | $99.2K | Purchase | 8,250 | $12.02 | Discretionary |
| Mar 19, 2008 | OMRI | $170.6K | Purchase | 13,940 | $12.24 | Discretionary |
| May 31, 2007 | OMRI | $0 | Award | 2,000 | $N/A | Discretionary |
| Dec 20, 2006 | OMRI | $2.0M | Sale | 67,394 | $30.08 | Discretionary |